Literature DB >> 7524160

Factor VIII inhibitors: structure and function in autoantibody and hemophilia A patients.

L W Hoyer1, D Scandella.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7524160

Source DB:  PubMed          Journal:  Semin Hematol        ISSN： 0037-1963            Impact factor:   3.851


× No keyword cloud information.
  11 in total

1.  [Prostate carcinoma associated spontaneous factor VIII:C inhibitor hemophilia. Successful therapy of severe hemorrhagic complication with porcine factor VIII in a 75-year-old patient].

Authors:  T Orth; M Schnütgen; W Herr; W J Mayet; W Dippold; R Wanitschke; K H Meyer zum Buschenfelde
Journal:  Med Klin (Munich)       Date:  1997-04-15

2.  Long-term expression of human coagulation factor VIII in a tolerant mouse model using the φC31 integrase system.

Authors:  Christopher L Chavez; Annahita Keravala; Jacqueline N Chu; Alfonso P Farruggio; Vanessa E Cuéllar; Jan Voorberg; Michele P Calos
Journal:  Hum Gene Ther       Date:  2012-01-26       Impact factor: 5.695

Review 3.  Immunomodulation for inhibitors in hemophilia A: the important role of Treg cells.

Authors:  Carol H Miao
Journal:  Expert Rev Hematol       Date:  2010-08       Impact factor: 2.929

4.  Platelet binding sites for factor VIII in relation to fibrin and phosphatidylserine.

Authors:  Gary E Gilbert; Valerie A Novakovic; Jialan Shi; Jan Rasmussen; Steven W Pipe
Journal:  Blood       Date:  2015-07-10       Impact factor: 22.113

Review 5.  Acquired Hemophilia A: Current Guidance and Experience from Clinical Practice.

Authors:  Allyson M Pishko; Bhavya S Doshi
Journal:  J Blood Med       Date:  2022-05-11

6.  Epitope-specific tolerance induction with an engineered immunoglobulin.

Authors:  E T Zambidis; D W Scott
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

7.  CD4+FOXP3+ regulatory T cells confer long-term regulation of factor VIII-specific immune responses in plasmid-mediated gene therapy-treated hemophilia mice.

Authors:  Carol H Miao; Benjamin R Harmeling; Steven F Ziegler; Benjamin C Yen; Troy Torgerson; Liping Chen; Roger J Yau; Baowei Peng; Arthur R Thompson; Hans D Ochs; David J Rawlings
Journal:  Blood       Date:  2009-08-27       Impact factor: 22.113

8.  Urological surgery in patients with hemorrhagic bleeding disorders Hemophilia A, Hemophilia B, von Willebrand disease: a retrospective study with matched pairs analysis.

Authors:  Sebastian Rogenhofer; Stefan Hauser; Anne Breuer; Guido Fechner; Stefan C Mueller; Johannes Oldenburg; Georg Goldmann
Journal:  World J Urol       Date:  2012-11-21       Impact factor: 4.226

9.  Acquired hemophilia successfully treated with oral immunosuppressive therapy.

Authors:  J J Lee; I J Chung; M R Park; D H Yang; S H Cho; D W Ryang; H J Kim
Journal:  Korean J Intern Med       Date:  2000-07       Impact factor: 2.884

10.  Curing hemophilia A by NHEJ-mediated ectopic F8 insertion in the mouse.

Authors:  Jian-Ping Zhang; Xin-Xin Cheng; Mei Zhao; Guo-Hua Li; Jing Xu; Feng Zhang; Meng-Di Yin; Fei-Ying Meng; Xin-Yue Dai; Ya-Wen Fu; Zhi-Xue Yang; Cameron Arakaki; Ruijun Jeanna Su; Wei Wen; Wen-Tian Wang; Wanqiu Chen; Hannah Choi; Charles Wang; Guangping Gao; Lei Zhang; Tao Cheng; Xiao-Bing Zhang
Journal:  Genome Biol       Date:  2019-12-16       Impact factor: 13.583
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.